Par Launches Generic Zofran ODT Following FDA Clearance
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency also clears Dr. Reddy’s immediate-release ondansetron formulation which the Indian firm said it will launch shortly.
You may also be interested in...
Dr. Reddy’s Tops Billion Dollar Mark In First Nine Months Of Fiscal 2007
Indian generic drug maker achieved the milestone on acquisitions supported by a “strong and profitable” growth engine.
Dr. Reddy’s Tops Billion Dollar Mark In First Nine Months Of Fiscal 2007
Indian generic drug maker achieved the milestone on acquisitions supported by a “strong and profitable” growth engine.
Dr. Reddy's Tops Billion Dollar Mark In First Nine Months Of Fiscal 2007
Dr. Reddy's Laboratories reported revenues exceeding $1 billion for the first time during the first nine months of fiscal 2007 (ended Dec. 31)